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Abstract: Apart from alterations of target proteins of fluroquinolones, multidrug resistant (MDR) S. aureus can
also mediated their resistance via overexpression of efflux pump. However, this mechanism is not well
characterized. Absence of known antibiotic resistance genes (ARGs) in the MDR S. aureus isolates have led us to
find other mechanism of resistance which could be responsible for their resistance. Therefore, this study was
performed to identify the MDR efflux pump genes and evaluate the activity through Ethidium Bromide Cartwheel
(EtBrCW) method. The MDR S. aureus were isolated from local hospital wastewater in Kuala Lumpur. 9 of the
MDR S. aureus isolates were subjected to PCR for the detection of MDR efflux pump genes. The EtBrCW was
used to demonstrate efflux activity as a mechanism of resistance in S. aureus. The result showed only 2 isolates
possessed efflux pump genes with low efflux activity. It was observed that many of the isolates did not have
conserved MDR efflux pump genes, suggesting there may be other mechanisms of resistance that need further
exploration. The fast spreading of these resistance genes could pose serious risk to public health and emergence of
superbug which is difficult to treat with available antibiotic.
Keywords: Multidrug resistant, Staphylococcus aureus, hospital wastewater, antibiotic resistant genes, efflux
pump, efflux pump genes.
1. Introduction
Multidrug resistance (MDR) Staphylococcus aureus (S. aureus) remains as one of the most important bacterial
pathogens in the public health domain due to its high virulence and capability to cause multiple ailments ranging from
complicated skin infections to life threatening conditions such as pneumonia, endocarditis and toxic shock syndrome.
This pathogen is relatively abundant both in the community and healthcare facilities. Besides its pathogenic potential,
these bacteria have been able to develop resistance to almost all classes of antibiotics [1]. Excessive and overuse of
these antibiotics in medical field resulting in many antibiotics are released in water environment coming from hospitals
which increase the development of ARGs in bacteria [2]. Hospital effluent contained high numbers of antimicrobial
residues and pathogens that are non-stop released into the environment especially in wastewater [3]. Moreover, hospital
effluent is found to be main hotspots for horizontal genes transfer, which can spread the gene of ARGs and virulence
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factors whether among interspecies and intraspecies of the bacteria [4]. Horizontal gene transfer is the common
mechanism to transfer the genetic information [5]. This method is common among bacteria because it is efficient to
contribute to the development, maintenance, and spreading ARGs among the bacteria. Spread of these ARGs are
becoming a great concern nowadays, because it could pose serious public health threats when disseminated to the
natural environment such as river water. Additionally, certain pathogenic bacteria have been found in Malaysia’s river
water and this can be passed simply through drinking water and unexpectedly affected humans [6, 7]. River water that
is exposed to the risk of contamination should be studied carefully to avoid threaten human health and environmental
quality [7]. Transfer of these resistance determinant to the river water could provide toxic effect on the microbial
communities in the natural environment and development of superbug from the environment making the treatment of
bacterial infections more difficult.
In Malaysia, the usage antibiotics has been increasing rapidly over the last decades till now. The classes of
antibiotics that are most frequently prescribed by Malaysian hospitals are Penicillin, Cephalosporins, Fluroquinolones,
Aminoglycosides, Sulfamethoxazole, Tetracycline and Phenicol. Starting in the 1950s, S. aureus developed resistance
to penicillin. This is followed by resistance to methicillin, about a decade later, due to the activity of PBP2a protein [8].
Because of this, fluroquinolones and glyco-peptides class of antibiotics has remained as a common and effective
therapy against S. aureus. Fluroquinolones antibiotic have been used for the treatment of severe or resistant S. aureus
infections since the late of 1980s [9]. Fluoroquinolones are potent, broad-spectrum antibiotics that are derived from the
quinolone family of antibiotics. It is synthetically constructed through modification of 1-alkyl-1,8-naphthyridin-4-one-
3-carboxylic acid [10]. The use of fluoroquinolones for the effective treatment has been impaired by the rapid
emergence of fluoroquinolone resistance. Fluoroquinolones resistance in S. aureus is mainly due to mutations in the
quinolone resistance determining region (QRDR) of genes encoding the target enzymes (topoisomerase IV and DNA
gyrase). Mechanisms of fluoroquinolone resistance in S. aureus have been extensively studied and are high resistance
to these agents are mostly related to mutations in the drug targets, topoisomerase IV and DNA gyrase [11]. However,
other than these enzyme mutations, fluoroquinolone resistance can also be mediated by drug efflux, a mechanism that is
not well characterized. Bacterial multidrug resistance may be mediated by the overexpression of efflux pump [12]. This
overexpression of efflux pump is mostly related to the mutations within the promoter region of the MDR efflux pump
gene.
Efflux pumps are membrane protein that are present in cytoplasmic membrane in bacteria cell. The function of
efflux pumps is for expelling and extruding harmful substances out from the bacterial cell [13]. Efflux pumps have their
own substrate specificity, where the substrate is specific to the antibiotic or a class of antibiotic. For MDR efflux
pumps, they are capable of extrude more than one class of antibiotic and other structural antimicrobial compounds [11].
They are major facilitator superfamily (MFS), the small multidrug resistance family (SMR), the resistance -nodulation –
cell division (RND) superfamily, the multidrug and toxic compound extrusion (MATE) family, and the adenosine-
triphosphate (ATP) binding cassette (ABC) superfamily) [13]. Most fluoroquinolone drugs are small enough to cross
the cytoplasmic membrane and then reach their targets in the cell cytoplasm. They also have charge characteristics that
allow them to cross the outer membrane through porin proteins, which form general diffusion channels and can cross
the cytoplasmic membrane via diffusion [14]. Recently, resistance caused by reduced accumulation has been shown to
require the presence and enhanced expression of endogenous efflux systems that actively pump drug from the
cytoplasm in S. aureus [15]. There are several MDR efflux pumps related to fluroquinolones resistance that have been
identified in the S. aureus such as NorA, NorB, MepA and MdeA [15]. Therefore, the objectives of this study were to
identify the ciprofloxacin MDR efflux pumps presence in our MDR S. aureus and to assess the activity of the efflux
pumps. Detection of MDR efflux pump in our MDR S. aureus isolates is crucial for explaining the fluroquinolones
resistance characteristic displayed by these isolates. Absence of known efflux pump ARGs in these isolates might be a
good model in providing us fundamental knowledge to solve the antibiotic resistance problem.
2. Method
2.1 Isolation of MDR S. aureus from hospital wastewater
Hospital wastewater was taken from local hospital wastewater and were directly processed after sampling. For the
isolation of MDR S. aureus, a selective medium, Mannitol Salt agar (MSA) was used. A serial dilution of the
wastewater was performed and each of the dilution was spread on the MSA plate and incubated at 37 °C for 24 hours.
A pure culture of 9 S. aureus isolates obtained were recognized by the appearance of yellow colonies on MSA.
2.2 Phenotypic test of MDR S. aureus isolates
These 9 S. aureus isolates were grown on the MSA containing therapeutic concentration of ampicillin (30 µL/L),
gentamicin (10), trimethoprim-sulfamethoxazole (1.25/23.75), erythromycin (15), chloramphenicol (30), tetracycline
(15), kanamycin (30), nalidixic acid (30), vancomycin (15) and ciprofloxacin (5) to observe for the multidrug resistance
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characteristic. These 9 isolates were also subjected to Kirby Bauer disk diffusion test for the zone of inhibition
diameter. These was done according to the CLSI guidelines.
2.3 Bacterial DNA extraction
Total DNA was isolated from S. aureus grown in 30 ml of nutrient broth at 37 ℃ with shaking overnight. Cells
were harvested by centrifugation at 10,000 rpm for 2 minutes. The cell pellet was resuspended in 480 μL of EDTA and
120 µL of 20 mM lysozyme. The solution was incubated for 1 hour at 37 ℃ and then centrifuged at 10,000 rpm for 2
minutes. DNAwas extracted with phenol/chloroform and precipitated in 70 % ethanol for purification. The precipitated
DNAwas dissolved in 70 µL of sterile ultrapure water and stored at -20 ℃ until used.
2.4 PCR for Ciprofloxacin Efflux Pump Genes
PCR amplification was performed using a 20 µl reaction mixture composed of 12.3 µL sterilized Milli-Q water,
4.0 µL 5x PCR buffer, 1.6 µL MgCl2, 0.4 µL dNTPs, 0.3 µL of each forward and reverse primers, 0.1 µL Taq
polymerase, and 2 µL of purified DNA. The PCR protocol consisted of denaturation for 5 min at 94 °C; 35 cycles of 30
sec at 98 °C, 45 sec at 55 °C, and 45 sec at 72 °C; and a final extension step of 10 min at 72 °C. Amplified PCR
products were electrophoresed on a 2 % agarose gel in a 1X Tris-acetate EDTA (TAE) buffer, stained with Diamond
Nucleic Acid Dye (Promega, Madison, WI), and viewed under UV light. Nucleotide sequences and annealing
temperatures for each primer used in this study are shown in Table 1.
Table 1 - PCR primers with MDR efflux pumps gene targeted used in this study.
Genes
targeted
Primer sequence (5’-3’) Amplicon
size (bp)
Ta (℃) Reference
norA F; TTCACCAAGCCATCAAAAAG
R; CTTGCCTTTCTCCAGCAATA
mdeA F; AACGCGATACCAACCATTC
R; TTAGCACCAGCTATTGGACCT
mepA F; ATGTTGCTGCTGCTCTGTTC
620 45 [11]
677 53 [11]
718 53 [11]
R; TCAACTGTCAAACGATCACG
F: Forward primer R: Reverse primer
2.5 Ethidium Bromide Agar Cartwheel Method (EtBrCW)
Tryptic soy agar (TSA) plates containing different concentrations (0.5, 1.0. 1.5, 2.0, and 2.5 mg/mL) of ethidium
bromide (EtBr) were used to assess the activity of efflux pumps. S. aureus isolates were swabbed onto EtBr-TSA plates
as shown in Fig.1 below and incubated at 37 ℃ for 16 hours. For a control, a TSA plate with 0 mg/mL of EtBr was
prepared. After incubation, all agar plates were viewed and examined under a Gel-Doc XR apparatus (BioRad,
Hercules, CA) and the TSA plates were photographed.
Fig. 1 - 9 MDR S. aureus isolates were swabbed onto EtBr agar plate of TSA according to these patterns
3. Results
3.1 Susceptibility data of the 9 isolates
All the 9 isolates were able to grow well on MSA containing certain concentration of antibiotics and were resistant
to all the antibiotic tested (Table 2). MDR bacteria is defined when the bacteria are resistance to more than 3 antibiotic
classes tested.
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Table 2 - Antibiotic susceptibility in the MDR S. aureus isolates
ISOLATES ANTIBIOTICS
A
M
CFX GM
N
KN
M
ER
M
T
M-
NA
L
CM
P
TE
T
VA
N
1- R R I R R R R R R R
1- R R R R R R R R R R
1- R R R R R R R I I R
2- R R R R R R R R I R
2- R R R R R R R R R R
2- R R R R R R R R R R
3- R R R R R R R R I R
3- R R R R R R R R R R
3- R R R R R R R R R R
R:
R i t t
I: Intermedi
t
3.2 Molecular detection of efflux pump genes
Our results show that a high percentage of our isolates did not possess fluroquinolones MDR efflux pump genes.
Amplification of the selected genes by PCR showed only 2 isolates possessed MDR efflux pump. A single clear band
was observed on the agarose gel for isolate 3-36 at 677 bp and 3-59 at 718 bp, indicating the presence of mepA and
mdeA genes in these isolates (Fig.2). However, none of the isolates showed presence of norA gene (Table 3).
Table 3 - Detection of known efflux pumpARGs in the MDR S. aureus isolates
GENES
1-17 1-25 1-64 2-
18
ISOLATE
S
2
2-75 3-36 3-49 3-59
parC - - + - - - + + -
gyrA + - - + + - + - -
norA - - - - - - - - -
mdeA - - - - - - - - +
mepA - - - - - - + - -
(a) (b)
Fig. 2 - a) PCR amplification for mdeA appeared as a single band with a size fragment equals to 677 bp in 3-59
isolate b) PCR amplification for mepA appeared as a single band with a size fragment equals to 718 bp in 3-36
isolate
3.3 Efflux PumpActivity by EtBrCW
EtBrCW result exhibited similar fluorescence for each S. aureus isolates on agar plates containing increasing
concentrations of EtBr (data not shown) when compare to the control. Even at high concentration of EtBr (2.5 mg/L),
the fluorescence of all isolates remains the same and this indicates the efflux pump present in these isolates have very
low efflux activity system because they do not capable to extrude the EtBr from the cell.
4. Discussion
Our result showed that all 9 S. aureus isolates were resistant to 10 antibiotics tested indicated that the antibiotic
resistance problem in Malaysia is increasing. These bacteria were isolated from local hospital wastewater, which
contain high concentration of antibiotics and pathogenic bacteria. Continuous release of antibiotic into the wastewater
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has provided antibiotic selective pressure that triggered the bacteria to acquire the resistance genetic materials from
other bacteria species [16]. In addition, the climate in Malaysia could be one of the key factors influencing the
transmission of the ARGs among the bacteria. It has been mentioned by Leekha et al. (2012) that the climate may play
a role in contributing to antibiotic resistance in S. aureus [17]. Hot and high humidity condition in the country speed up
the bacterial replication rate and transmission. Mutations in chromosomal DNA occur at a low level every time the
DNA is copied during growth. This variation causes differences in how the organism interacts with the environment,
which leads to evolution by natural selection when the population (each containing different mutants) is faced with a
selective pressure [18]. Antibiotics are a strong selective pressure for bacterial populations. They remove bacteria that
do not have the relevant resistance-causing chromosomal mutations, and select for bacteria that have the mutations
[18]. Pathogen with new genetic material are evolving to adapt to the condition (bacterial has the tendency to acquire
the new genetic material which allows them to survive in certain conditions) and leading to the spread of new pathogen
with new genetic characteristics.
These MDR bacteria were furthered subjected to PCR analysis to observe for the known ARGs responsible for
their resistance. Interestingly, PCR amplification showed that high percentage of MDR S. aureus isolates did not have
MDR efflux pump genes. In our previous paper, PCR amplification has been done on the same isolates for detection of
gyrA and parC genes. 6 isolates (1-17, 1-64, 2-18, 2-43, 3-36 and 3-49) possessed these 2 genes [19]. But the rest of the
MDR isolates (1-25, 2-75 and 3-59) showed absence of parC and gyrA genes. These showed that there may be other
resistance mechanism responsible for the resistance. Therefore, in this study, we have selected the isolates that showed
resistance to fluroquinolone to observe if other mechanism of resistance (expelling the drugs out through efflux pump),
existed in our MDR isolates. However, PCR result of these MDR isolates demonstrated that only 2 efflux pump genes
were amplified (mepA and mdeA).
The selection of the MDR efflux pump genes used in this study are selected based on their frequent occurrence in
phenotypically resistant S. aureus isolates especially NorA efflux pump. NorA efflux pump is one of the most common
efflux pumps studied in S. aureus [13]. NorA efflux transporter was first identified in 1990 and responsible for
intermediate level of resistance to fluroquinolones in S. aureus [13]. Several studies have shown that NorA can extrude
an array of chemically and structurally dissimilar compounds such as hydrophilic fluroquinolones, EtBr and quaternary
compounds [20,21]. Increased resistance to fluroquinolone biocides and dyes has been associated with Nor-A mediated
efflux, via the increased expression of the norA gene [22]. Recent study showed that frequency of NorA overexpressing
strains is high in S. aureus isolates collected from various regions in the United State [23]. In addition to that, a study in
Portugal also showed that all S. aureus isolates carried norA gene [12]. However, in this study, all 9 MDR isolates
showed absence of norA gene, which is contradicted to what the other studies have found. This indicate that norA gene
is not involved contributing to the MDR resistance phenotypes in our 9 isolates.
Other than NorA efflux pump, another important fluroquinolone MDR efflux pump is MepA. MepA is encoded by
chromosomal gene mepA and it was the first MDR transporter from MATE family in S. aureus [13]. MepA was found
to be associated with MDR phenotype and conferring low level of resistance to quaternary ammonium compounds,
EtBr, as well as antibiotic from class of the glycylcyclines [13]. However, it was shown that fluroquinolone such as
ciprofloxacin is a weak substrate of MepA [24,25]. Detection of mepA gene in the 3-36 isolate indicates that expression
of mepA gene may contribute slightly to the fluroquinolone resistance phenotype shown by this isolate together with
high expression of parC and gyrA genes. Although high level of resistance may not occur as a result of MDR efflux
pump alone, the association of over-expression of specific genes among highly resistant clinical isolates cannot be
ignored [26,27]. Therefore, intrinsic resistance to antibiotics of some isolates may be largely due to efflux systems
[28,29]. Synergic reaction increases in resistance has been seen with over expression of efflux systems as well as target
site mutations can lead to highly resistant bacteria that are difficult to treat with the antibiotics that are currently
available [13].
Efflux pump MdeA, was encoded by the chromosomal gene mdeA and it was identified in an open reading frame
expression library of the S. aureus genome [30]. The overexpression of mdeA was associated to increased resistance to
the biocides benzalkonium chloride, EtBr and to the antibiotics novobiocin, mupirocin and fusidic acid [30]. A study
has shown that fluroquinolones ciprofloxacin is a weak substrate of this pump [30]. In this study, we detected the
presence of mdeA gene in our 3-59 isolate. In contrast to other study, they identified that all S. aureus isolates carried
the mdeA gene [13]. Our result indicates that, despite being a weak substrate to the MdeA pump, the expression of this
gene may have contributed to the MDR resistance phenotype. According to Huang et al., (2004), overexpression of this
gene can be achieved by the occurrence of mutations in the mdeA promoter region [31].
EtBrCW is a widely used agar-based method that has been modified to rapidly screen for MDR isolates that show
an over expression of their efflux systems [32]. This system relies on the ability of the bacteria to expel a fluorescent
molecule that is substrate for most efflux pumps, EtBr [32]. This method has been proved to be a valuable tool for rapid
screening of efflux pump activity [13]. Analysis of the efflux pump activity by EtBrCW in our isolates showed these
isolates have low efflux pump activity. Even at high concentration of EtBr, the isolates showed similar f luorescence.
According to Martins et al., (2010), if isolates shows fluorescence at lower EtBr concentration, these isolates are
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identified to have less active efflux systems compared to that which fluorescence at high EtBr concentrations [32]. This
result is consistent with the PCR result which also showed absence of most known efflux pump genes except for isolate
3-36 and 3-59. Low efflux pump activity indicates that these bacteria may not be using efflux pump as their primary
way of resisting the antibiotic action, but also other resistance mechanism which need further exploration. Their
resistance in the S. aureus isolates could be mediated by other different mechanism of resistant excluding mutations of
enzymes. However, in this study, we do not assess the expression of the efflux pump genes through determination of
MIC values for ciprofloxacin, and it is a limitation that need to be noted.
5. Conclusion
From this study, it can be concluded that MDR S. aureus were resistant due to the presence of genes encoded for
enzymes mutations and efflux pumps. However, 2 of the MDR isolates (1-25 and 2-75) showed absence of these genes,
indicating some new mechanism of resistance must be existed and further experiments on these 2 unique isolates need
to be carry out. A new resistance mechanism could be associated with the environmental conditions in Malaysia.
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